Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Retraction Note: Verteporfin-induced formation of protein cross-linked oligomers and high molecular weight complexes is mediated by light and leads to cell toxicity.
Journal: Scientific reports
Published: May 14, 2024
PATIENT WITH UNILATERAL CHOROIDAL AND SEROUS RETINAL DETACHMENT WITH A HISTORY OF TREATED PROSTATE CANCER AND UNTREATED SARCOIDOSIS.
Journal: Retinal cases & brief reports
Published: February 15, 2020
RELATIVE QUIESCENCE OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION AFTER RESOLUTION OF POSTINJECTION ENDOPHTHALMITIS.
Journal: Retina (Philadelphia, Pa.)
Published: December 05, 2019
POSTERIORLY INSERTED VITREOUS BASE: Preoperative Characteristics, Intraoperative Findings, and Outcomes After Vitrectomy.
Journal: Retina (Philadelphia, Pa.)
Published: March 19, 2019
Evaluation of computer-based retinopathy of prematurity (ROP) education for ophthalmology residents: a randomized, controlled, multicenter study.
Journal: Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
Published: May 10, 2018
Verteporfin inhibits growth of human glioma in vitro without light activation.
Journal: Scientific reports
Published: February 13, 2017
Verteporfin-induced formation of protein cross-linked oligomers and high molecular weight complexes is mediated by light and leads to cell toxicity.
Journal: Scientific reports
Published: January 04, 2017
Validation of the Retinal Detachment after Open Globe Injury (RD-OGI) Score as an Effective Tool for Predicting Retinal Detachment.
Journal: Ophthalmology
Published: July 13, 2016
Uveal melanoma cell growth is inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase.
Journal: Investigative ophthalmology & visual science
Published: May 01, 2014
Effects of metformin on retinoblastoma growth in vitro and in vivo.
Journal: International journal of oncology
Published: March 28, 2014
The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation.
Journal: Experimental eye research
Published: March 11, 2014
Last Updated: 09/26/2026